SC US (TTGP), LTD.SC US (TTGP), LTD.

Institutional investor · Portfolio as of Q3 2020

SEC EDGAR SourceSEC Filings

Top Holdings11 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

SNOWFLAKE INC-CLASS A

17.5M$4.4B42.2%$259.130.00%
1 qtr
New
100

UNITY SOFTWARE INC

33M$2.9B27.7%$94.920.00%
1 qtr
New
100
MDLAMDLADelisted

MEDALLIA INC

44.4M$1.2B11.7%
5 qtrssince 2019-Q3
Unchanged
0
BEKEBEKE
ADR

KE HOLDINGS INC-ADR

11M$672.1M6.5%$62.040.00%
1 qtr
New
100
CELLCELLDelisted

BERKELEY LTS INC

8M$614.5M5.9%
1 qtr
New
100
PDDPDD
ADR

PDD HOLDINGS INC

5.3M$390.3M3.8%$24.80+197.18%
7 qtrssince 2019-Q1
Unchanged
0

BRIDGEBIO PHARMA INC

2.5M$95.5M0.9%$26.97+39.12%
6 qtrssince 2019-Q2
Unchanged
0
SUMOSUMODelisted

SUMO LOGIC INC

3.4M$74.2M0.7%
1 qtr
New
61

QUINCE THERAPEUTICS INC

1M$52M0.5%$42.51+18.37%
6 qtrssince 2019-Q2
Unchanged
0

BLOCK INC

2,856$464,0000.0%$74.92+119.98%
7 qtrssince 2019-Q1
Unchanged
0
EBEBDelisted

EVENTBRITE INC

42,102$457,0000.0%$17.49-37.11%
5 qtrssince 2019-Q3
Unchanged
0
$10.4B
AUM
11
Positions
Q3 2020
Filing
Rating · 3.5
Quarterly Portfolio Change
+42%Q2'19$1.5B+54%Q3'19$2.3B+3%Q4'19$2.3B-44%Q1'20$1.3B+695%Q3'20$10.4B
Activity profile
$ moved · Q3'20
New100%Increased0%Decreased0%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.7 quarters
<1Q45%1-4Q0%1-2Y55%2Y+0%

SC US (TTGP), LTD. manages $10.4B across 11 positions as of Q3 2020. Top holdings: SNOW (42.2%), U (27.7%), MDLA (11.7%). Fund DNA: Concentrated Value. HoldingsIntel Rating: 3.5/5.0.

Q3 2020 Summary

Added 5 new positions. Top move: SNOW (NEW, conviction 100). Portfolio: $10.4B across 11 positions.

Top holdings by portfolio weight

Total AUM$10B
SNOW42.24%
U27.72%
MDLA11.73%
BEKE6.48%
CELL5.92%
PDD3.76%
BBIO0.92%
SUMO0.72%
QNCX0.50%
XYZ0.00%
Other0.00%

Portfolio allocation by GICS sector

Sectors6
Technology69.96%
Unknown18.37%
Real Estate6.48%
Consumer Cyclical3.76%
Healthcare1.42%
Communication Services0.00%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Technology, Unknown
Compare DNA across all funds
7-dimension quality assessment
Strong(3.5 / 5.0)
Track Record51
Conviction39
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
2Q
FIGFIGFIGMA INC-CL A
Q1 2026 Q2 2026+1.5M shares-$460.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used